A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy

This publication has 22 references indexed in Scilit:

• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1989
• Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
  Journal of Clinical Oncology, 1989
• Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics
  Chemico-Biological Interactions, 1989
• High doses of prochlorperazine for cisplatin-induced emesis: A prospective, random, dose–response study
  Cancer, 1987
• Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
  BMJ, 1986
• A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
  Journal of Clinical Oncology, 1985
• Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients
  Cancer, 1985
• Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
  Journal of Clinical Oncology, 1984
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981